Trials / Completed
CompletedNCT01723891
Study To Compare Safety and Pharmacokinetic Properties of Surfolase Capsule and HT-002-01 in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Hyundai Pharmaceutical Co., LTD. · Industry
- Sex
- Male
- Age
- 20 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
Study to compare safety and pharmacokinetic properties of surfolase capsule and HT-002-01 after oral administration for one day in healthy male volunteer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Surfolase capsule | |
| DRUG | HT-002-01 |
Timeline
- Start date
- 2012-11-01
- First posted
- 2012-11-08
- Last updated
- 2012-11-08
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01723891. Inclusion in this directory is not an endorsement.